Literature DB >> 10706853

Cell adhesion receptors in lymphoma dissemination.

P Drillenburg1, S T Pals.   

Abstract

Regulated lymphocyte trafficking is essential for the control and integration of systemic immune responses. This homing process disperses the immunologic repertoire, guides lymphocyte subsets to the specialized microenvironments that control their differentiation and survival, and targets immune effector cells to sites of antigenic insult. This review discusses data indicating that the adhesion receptors regulating the trafficking of normal lymphocytes are also expressed and functionally active in their malignant counterparts, the non-Hodgkin lymphomas. These "homing receptors" appear to mediate the highly tissue-specific dissemination of specific lymphoma subtypes, such as lymphomas of the mucosa-associated lymphoid tissues and lymphomas of the skin. Furthermore, as a result of their capability to enhance lymphoma dissemination and to transduce signals into the cell, promoting cell growth and survival, adhesion receptors may contribute to lymphoma aggressiveness. Taken together, the data offer a framework for understanding the dissemination routes of non-Hodgkin lymphomas and suggest that adhesion receptors, specifically those of the CD44 family, may present useful tools to predict prognosis in patients with lymphomas. (Blood. 2000;95:1900-1910)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10706853

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells.

Authors:  C J Dimitroff; J Y Lee; R C Fuhlbrigge; R Sackstein
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 2.  Pediatric non-Hodgkin's lymphoma: clinical and biologic prognostic factors and risk allocation.

Authors:  Sheila Weitzman; Kaveri Suryanarayan; Howard J Weinstein
Journal:  Curr Oncol Rep       Date:  2002-03       Impact factor: 5.075

Review 3.  Tissue-specific homing of immune cells in malignant skin tumors.

Authors:  Hajnalka Jókai; Márta Marschalkó; Judit Csomor; József Szakonyi; Orsolya Kontár; Gábor Barna; Sarolta Kárpáti; Péter Holló
Journal:  Pathol Oncol Res       Date:  2012-04-24       Impact factor: 3.201

4.  Molecular markers (PECAM-1, ICAM-3, HLA-DR) determine prognosis in primary non-Hodgkin's gastric lymphoma patients.

Authors:  Alexander Darom; Ilias P Gomatos; Emmanuel Leandros; Emmu Chatzigianni; Dimitris Panousopoulos; Manousos M Konstadoulakis; George Androulakis
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

5.  Jun-regulated genes promote interaction of diffuse large B-cell lymphoma with the microenvironment.

Authors:  Marzenna Blonska; Yifan Zhu; Hubert H Chuang; M James You; Kranthi Kunkalla; Francisco Vega; Xin Lin
Journal:  Blood       Date:  2014-12-22       Impact factor: 22.113

6.  Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse.

Authors:  Diego Villa; Joseph M Connors; Laurie H Sehn; Randy D Gascoyne; Kerry J Savage
Journal:  Haematologica       Date:  2011-04-12       Impact factor: 9.941

7.  Differentiation of single lymphoma primary cells and normal B-cells based on their adhesion to mesenchymal stromal cells in optical tweezers.

Authors:  Kamila Duś-Szachniewicz; Sławomir Drobczyński; Marta Woźniak; Krzysztof Zduniak; Katarzyna Ostasiewicz; Piotr Ziółkowski; Aleksandra K Korzeniewska; Anil K Agrawal; Paweł Kołodziej; Kinga Walaszek; Zbigniew Bystydzieński; Grzegorz Rymkiewicz
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

8.  NOD/SCID mouse model of canine T-cell lymphoma with humoral hypercalcaemia of malignancy: cytokine gene expression profiling and in vivo bioluminescent imaging.

Authors:  M V P Nadella; W C Kisseberth; K S Nadella; N K Thudi; D H Thamm; E A McNiel; A Yilmaz; K Boris-Lawrie; T J Rosol
Journal:  Vet Comp Oncol       Date:  2008-03       Impact factor: 2.613

9.  Microarray analysis of B-cell lymphoma cell lines with the t(14;18).

Authors:  Ryan S Robetorye; Sandra D Bohling; John W Morgan; G Chris Fillmore; Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2002-08       Impact factor: 5.568

10.  Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling.

Authors:  M Hahn; J-P Bürckert; C A Luttenberger; S Klebow; M Hess; M Al-Maarri; M Vogt; S Reißig; M Hallek; A Wienecke-Baldacchino; T Buch; C P Muller; C P Pallasch; F T Wunderlich; A Waisman; N Hövelmeyer
Journal:  Leukemia       Date:  2017-06-01       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.